The irritable bowel syndrome treatment market size was valued at $1,071 million in 2018, and is estimated to reach $2,012 million by 2026, registering a CAGR of 8.2% from 2019 to 2026. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects the large intestine. Signs & symptoms include abdominal pain, bloating, gas, cramping, and constipation or diarrhea. There are three

アプリをインストールして、知り合いの最新の活躍をフォローしよう